AnalystsStephen Brozak
Stephen Brozak's Stock Forecasts

Sectors:

Healthcare

Industries:

Biotechnology

Analyst Ranking

Top 41%

#1997 out of 4872 analysts

Average Return

+24.98%

Win Rate

100%3 out of 3

Risk vs Reward

Poor

Good

Stephen Brozak's 5 best and worst ratings

Name / Ticker	Gain/Loss	Entry Price	Exit Price	Period	Rating
Paratek Pharmaceuticals IncPRTK	+51.32%	$4.17	$6.31	2020-01-07 - 2021-01-08	Buy
Cidara Therapeutics IncCDTX	+15.75%	$146.00	$123.00	2017-07-27 - 2017-08-11	Sell
Cidara Therapeutics IncCDTX	+7.88%	$19.93	$21.50	2024-12-04 - 2025-05-05	Strong Buy

Stephen Brozak Analyst Color

Get additional color on Stephen Brozak's coverage of popular stocks

Stephen Brozak's Stock Coverage

Name / Ticker	No. Ratings	Rating	Price Target	Upside/Downside	Action	Date
Cidara Therapeutics IncCDTX	4	Strong Buy	$45.00	+109.30%	Maintains	5 months ago
Arcturus Therapeutics Holdings IncARCT	1	Hold	$31.00	N/A	Downgrades	5 years ago
Paratek Pharmaceuticals IncPRTK	1	Buy	$6.00	N/A	Initiates Coverage On	5 years ago

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.